Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01884740
Recruitment Status : Recruiting
First Posted : June 24, 2013
Last Update Posted : March 10, 2020
Sponsor:
Information provided by (Responsible Party):
Weill Medical College of Cornell University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2025
Estimated Study Completion Date : January 2025